162 related articles for article (PubMed ID: 18752940)
1. Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.
Shen HC; Taggart AK; Wilsie LC; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2008 Sep; 18(18):4948-51. PubMed ID: 18752940
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists.
Deng Q; Frie JL; Marley DM; Beresis RT; Ren N; Cai TQ; Taggart AK; Cheng K; Carballo-Jane E; Wang J; Tong X; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2008 Sep; 18(18):4963-7. PubMed ID: 18760600
[TBL] [Abstract][Full Text] [Related]
3. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A).
Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP
J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767
[TBL] [Abstract][Full Text] [Related]
4. Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.
Skinner PJ; Cherrier MC; Webb PJ; Shin YJ; Gharbaoui T; Lindstrom A; Hong V; Tamura SY; Dang HT; Pride CC; Chen R; Richman JG; Connolly DT; Semple G
Bioorg Med Chem Lett; 2007 Oct; 17(20):5620-3. PubMed ID: 17804224
[TBL] [Abstract][Full Text] [Related]
5. GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole-tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a.
Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Taggart AK; Cheng K; Carballo-Jane E; Gerard Waters M; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2009 Apr; 19(8):2121-4. PubMed ID: 19307116
[TBL] [Abstract][Full Text] [Related]
6. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
[TBL] [Abstract][Full Text] [Related]
7. GPR109a agonists. Part 2: pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a.
Imbriglio JE; Chang S; Liang R; Raghavan S; Schmidt D; Smenton A; Tria S; Schrader TO; Jung JK; Esser C; Holt TG; Wolff MS; Taggart AK; Cheng K; Carballo-Jane E; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4472-4. PubMed ID: 20615702
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor.
Kim HY; Jadhav VB; Jeong DY; Park WK; Song JH; Lee S; Cho H
Arch Pharm Res; 2015 Jun; 38(6):1019-32. PubMed ID: 25599616
[TBL] [Abstract][Full Text] [Related]
9. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
[TBL] [Abstract][Full Text] [Related]
10. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.
Shen HC
Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484
[TBL] [Abstract][Full Text] [Related]
11. Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia.
Schmidt D; Smenton A; Raghavan S; Carballo-Jane E; Lubell S; Ciecko T; Holt TG; Wolff M; Taggart A; Wilsie L; Krsmanovic M; Ren N; Blom D; Cheng K; McCann PE; Gerard Waters M; Tata J; Colletti S
Bioorg Med Chem Lett; 2009 Aug; 19(16):4768-72. PubMed ID: 19592242
[TBL] [Abstract][Full Text] [Related]
12. Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
Boatman PD; Schrader TO; Kasem M; Johnson BR; Skinner PJ; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Taggart AK; Carballo-Jane E; Richman JG
Bioorg Med Chem Lett; 2010 May; 20(9):2797-800. PubMed ID: 20363624
[TBL] [Abstract][Full Text] [Related]
13. Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: optimization of in vitro activity.
Peters JU; Kühne H; Dehmlow H; Grether U; Conte A; Hainzl D; Hertel C; Kratochwil NA; Otteneder M; Narquizian R; Panousis CG; Ricklin F; Röver S
Bioorg Med Chem Lett; 2010 Sep; 20(18):5426-30. PubMed ID: 20724150
[TBL] [Abstract][Full Text] [Related]
14. Agonist lead identification for the high affinity niacin receptor GPR109a.
Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G
Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745
[TBL] [Abstract][Full Text] [Related]
15. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209
[TBL] [Abstract][Full Text] [Related]
16. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G).
Tunaru S; Lättig J; Kero J; Krause G; Offermanns S
Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840
[TBL] [Abstract][Full Text] [Related]
17. Future of GPR109A agonists in the treatment of dyslipidaemia.
Wanders D; Judd RL
Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
[TBL] [Abstract][Full Text] [Related]
18. Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.
van Veldhoven JP; Liu R; Thee SA; Wouters Y; Verhoork SJ; Mooiman C; Louvel J; IJzerman AP
Bioorg Med Chem; 2015 Jul; 23(14):4013-25. PubMed ID: 25737085
[TBL] [Abstract][Full Text] [Related]
19. The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties.
Imbriglio JE; DiRocco D; Bodner R; Raghavan S; Chen W; Marley D; Esser C; Holt TG; Wolff MS; Taggart AK; Waters MG; Tata JR; Colletti SL
Bioorg Med Chem Lett; 2011 May; 21(9):2721-4. PubMed ID: 21185185
[TBL] [Abstract][Full Text] [Related]
20. Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Gharbaoui T; Boatman PD; Sage CR; Chen R; Richman JG; Connolly DT; Semple G
J Med Chem; 2007 Apr; 50(7):1445-8. PubMed ID: 17358052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
